We are live on ! Find out more
GF

Gabelli Funds Portfolio holdings

AUM $14.8B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+32.24%
3 Year Est. Return
+88.06%
5 Year Est. Return
+130.29%
10 Year Est. Return
+486.58%
AUM
$14.1B
AUM Growth
+$963M
Cap. Flow
-$36.3M
Cap. Flow %
-0.26%
Top 10 Hldgs %
12.86%
Holding
1,287
New
192
Increased
280
Reduced
411
Closed
65

Top Buys

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$28.6M
2
BPMC
Blueprint Medicines
BPMC
+$21.9M
3
SKX
Skechers
SKX
+$16.9M
4
FARO
Faro Technologies
FARO
+$14M
5
DNB
Dun & Bradstreet
DNB
+$13M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$43M
2
BECN
Beacon Roofing Supply, Inc.
BECN
+$20.6M
3
DFS
Discover Financial Services
DFS
+$18M
4
FNA
Paragon 28, Inc.
FNA
+$16.8M
5
NEM icon
Newmont
NEM
+$16.2M

Sector Composition

Rank Sector Weight
1 Industrials 20.94%
2 Financials 12.8%
3 Communication Services 10.31%
4 Technology 10.08%
5 Utilities 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XRAY icon
926
Dentsply Sirona
XRAY
$2.59B
$729K 0.01%
45,908
-52,092
-53% -$779K
KE
927
Kimball Electronics
KE
$598M
$726K 0.01%
37,764
– –
GENC icon
928
Gencor Industries
GENC
$223M
$720K 0.01%
51,400
+8,800
+21% +$115K
AOUT icon
929
American Outdoor Brands
AOUT
$162M
$720K 0.01%
68,856
-900
-1% -$10.3K
EMR icon
930
Emerson Electric
EMR
$82.9B
$719K 0.01%
5,390
+100
+2% +$11.5K
BEPC icon
931
Brookfield Renewable
BEPC
$6.12B
$718K 0.01%
21,916
-584
-3% -$17.1K
TFC icon
932
Truist Financial
TFC
$63.2B
$718K 0.01%
16,700
– –
OMCL icon
933
Omnicell
OMCL
$1.86B
$717K 0.01%
+24,398
New +$730K
OLED icon
934
Universal Display
OLED
$3.71B
$711K 0.01%
4,600
– –
WTW icon
935
Willis Towers Watson
WTW
$27.9B
$705K 0.01%
2,300
– –
VST icon
936
Vistra
VST
$55.1B
$698K 0.01%
3,600
– –
MRCY icon
937
Mercury Systems
MRCY
$6.2B
$690K ﹤0.01%
12,809
– –
IIIV icon
938
i3 Verticals
IIIV
$395M
$687K ﹤0.01%
25,000
-5,000
-17% -$125K
FSBC icon
939
Five Star Bancorp
FSBC
$1B
$683K ﹤0.01%
+23,937
New +$658K
HBI
940
DELISTED
Hanesbrands
HBI
$682K ﹤0.01%
149,000
– –
AGCO icon
941
AGCO
AGCO
$8.78B
$681K ﹤0.01%
6,600
+600
+10% +$57.2K
NDAQ icon
942
Nasdaq
NDAQ
$51.5B
$676K ﹤0.01%
7,560
-790
-9% -$63.1K
FERG icon
943
Ferguson
FERG
$44.7B
$675K ﹤0.01%
3,100
+100
+3% +$18.4K
LNSR icon
944
LENSAR
LNSR
$68.8M
$672K ﹤0.01%
51,000
+37,500
+278% +$506K
GHM icon
945
Graham Corp
GHM
$1.22B
$668K ﹤0.01%
13,496
-1,000
-7% -$37.1K
JOUT icon
946
Johnson Outdoors
JOUT
$482M
$667K ﹤0.01%
22,036
-2,000
-8% -$52.3K
DGII icon
947
Digi International
DGII
$2.52B
$659K ﹤0.01%
18,900
-500
-3% -$15.3K
KEYS icon
948
Keysight
KEYS
$54.5B
$655K ﹤0.01%
4,000
– –
WAFD icon
949
WaFd
WAFD
$2.72B
$655K ﹤0.01%
+22,380
New +$634K
GRFS
950
Grifois
GRFS
$5.16B
$647K ﹤0.01%
71,548
– –
36 37
38
39 40

Similar funds

FCAS
First Command Advisory Services Fort Worth, Texas $14.8B AUM 18.11% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
CCM
Cantillon Capital Management New York $15.1B AUM 23.54% 1-Year Est. Return
AT
AMF Tjänstepension Stockholm, Sweden $15.1B AUM 30.1% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $15.1B AUM 26.53% 1-Year Est. Return

Gabelli Funds's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli Funds held 1,287 positions worth $14.1B, up 7.3% from $13.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Gabelli Funds's Q2 2025 filing shows 192 new, 280 increased, 411 reduced and 65 closed positions. Its largest new stake was Blueprint Medicines: 211,169 shares worth $27.1M. The largest sale was Intra-Cellular Therapies Inc., an estimated $43M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 21% a quarter earlier, followed by Financials and Communication Services.

  • Gabelli Funds's largest Q2 2025 buy was Blueprint Medicines: 211,169 shares worth $27.1M.
  • Gabelli Funds added most to SpringWorks Therapeutics in Q2 2025, an estimated $28.6M increase.
  • Gabelli Funds's biggest Q2 2025 reduction was Newmont, cutting an estimated $16.2M.
  • Gabelli Funds fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $43M.
  • Gabelli Funds's ten largest holdings make up 13% of its $14.1B portfolio in Q2 2025.
  • Gabelli Funds opened 192 new positions and closed 65 in Q2 2025.
  • Gabelli Funds's portfolio value rose 7.3% quarter-over-quarter to $14.1B.

Based on Gabelli Funds's 13F filing for Q2 2025, filed 13 Aug 2025.